Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)

Condition:   Thromboembolism
Interventions:   Drug: Dabigatran etexilate;   Drug: Warfarin
Sponsor:   Boehringer Ingelheim
Not yet recruiting - verified September 2016

Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation

Conditions:   Coronary Artery Bypass Grafting;   Postoperative Atrial Fibrilation;   Stroke;   Systemic Embolism;   Deep Venous Thrombosis
Interventions:   Drug: Apixaban;   Drug: Warfarin
Sponsors:   Sanford Health;   Bristol-Myers Squibb
Recruiting - verified September 2016

Compression Therapy Following Truncal Vein Endothermal Ablation And Distal Sclerotherapy

Condition:   Varicose Veins
Intervention:   Device: Class II Compression Stockings
Sponsor:   Oulu University Hospital
Recruiting - verified September 2016

Safety and Efficacy of IV TXA in Reducing Blood Loss and Transfusion in Hip Fractures

Conditions:   Hip Fractures;   Blood Loss
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsor:   Yale University
Not yet recruiting - verified September 2016

Prospective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients

Conditions:   Venous Thrombosis;   Pregnancy
Intervention:   Other: antepartum and postpartum
Sponsor:   Baylor College of Medicine
Active, not recruiting - verified September 2016

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Condition:   Venous Thrombosis and Pulmonary Embolism
Intervention:   Drug: Rivaroxaban (Xarelto, BAY 59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Not yet recruiting - verified September 2016

StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study

Condition:   Venous Thromboembolism
Intervention:   Drug: Rosuvastatin
Sponsor:   Ottawa Hospital Research Institute
Not yet recruiting - verified September 2016

New International CTEPH Database

Conditions:   Chronic Thromboembolic Pulmonary Hypertension;   CTEPH
Intervention:  
Sponsor:   International CTEPH Association
Active, not recruiting - verified September 2016

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Condition:   Venous Thromboembolism
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified September 2016

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Condition:   Neoplasms
Interventions:   Drug: Rivaroxaban;   Drug: Placebo
Sponsors:   Janssen Research & Development, LLC;   Bayer
Recruiting - verified September 2016

Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer

Conditions:   Pregnancy;   Deep Vein Thrombosis
Intervention:   Other: LEFt clinical decision rule
Sponsor:   Ottawa Hospital Research Institute
Recruiting - verified August 2016

Enoxaparin Metabolism in Reconstructive Surgery Patients

Conditions:   Venous Thromboembolism;   Deep Venous Thrombosis;   Pulmonary Embolus;   Reconstructive Surgery
Intervention:   Drug: Enoxparin
Sponsor:   University of Utah
Completed - verified September 2016

Predicting the Safety and Effectiveness of Inferior Vena Cava Filters

Condition:   Pulmonary Embolism
Intervention:   Device: IVC Filter
Sponsors:   New England Research Institutes;   IVC Filter Study Group Foundation (IDE Sponsor);   ALN Implants Chirurgicaux;   B. Braun Interventional Systems, Inc;   Bard Peripheral Vascular, Inc.;   Cook;   Cordis Corporation;   Rex Medical
Recruiting - verified October 2015

Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: PEAGE

Conditions:   Elderly;   Pulmonary Embolism;   Anticoagulants
Intervention:   Other: 4 blood samples
Sponsors:   Centre Hospitalier Universitaire de Saint Etienne;   Ministry of Health, France
Recruiting - verified September 2016

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Placebo
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified September 2016

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Epoetin alfa
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified September 2016

Postoperative Bleeding Prevention in Massive Bone Tumour Resection

Conditions:   Blood Loss;   Bone Tumour
Interventions:   Drug: Tranexamic Acid;   Drug: Fibrin glue;   Procedure: Electrocauterization
Sponsor:   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Terminated - verified September 2016

Prevention of Postoperative Bleeding in Subcapital Femoral Fractures

Conditions:   Hip Fracture;   Blood Loss
Interventions:   Drug: Tranexamic Acid;   Drug: Fibrin glue;   Procedure: Electrocauterization
Sponsor:   Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Completed - verified September 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsor:   Bayer
Recruiting - verified September 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin
Sponsor:   Bayer
Recruiting - verified September 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsor:   Bayer
Recruiting - verified September 2016

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Recruiting - verified August 2016

Clinical Randomisation of an Antifibrinolytic in Significant Head Injury

Condition:   Traumatic Brain Injury
Intervention:   Drug: Tranexamic Acid
Sponsor:   London School of Hygiene and Tropical Medicine
Recruiting - verified September 2016

Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)

Condition:   Ankylosing Spondylitis
Intervention:  
Sponsor:   Merck Sharp & Dohme Corp.
Active, not recruiting - verified September 2016